| 1 | Predictors of disease progression in HIV infection: a review (10.1186/1742-6405-4-11) | Abstract References ORCID License | 234.64 | 221 |
| 2 | Immune reconstitution inflammatory syndrome (IRIS): review o… (10.1186/1742-6405-4-9) | Abstract References ORCID License | 232.01 | 208 |
| 3 | Cerebrospinal fluid neopterin: an informative biomarker of c… (10.1186/1742-6405-7-15) | Abstract References ORCID License | 229.67 | 197 |
| 4 | Presence of the CYP2B6 516G> T polymorphism, increased pl… (10.1186/1742-6405-7-32) | Abstract References ORCID License | 204.92 | 111 |
| 5 | HIV-1 virologic failure and acquired drug resistance among f… (10.1186/1742-6405-11-9) | Abstract References ORCID License | 191.91 | 82 |
| 6 | Fosamprenavir or atazanavir once daily boosted with ritonavi… (10.1186/1742-6405-5-5) | Abstract References ORCID License | 185.13 | 70 |
| 7 | The HIV treatment cascade and care continuum: updates, goals… (10.1186/s12981-016-0120-0) | Abstract ORCID License | 182.95 | 274 |
| 8 | HLA-Cw*04 allele associated with nevirapine-induced rash in… (10.1186/1742-6405-6-22) | Abstract References ORCID License | 181.29 | 64 |
| 9 | Food assistance is associated with improved body mass index,… (10.1186/1742-6405-7-33) | Abstract References ORCID License | 181.29 | 64 |
| 10 | Antiretroviral treatment adherence and its determinants in S… (10.1186/1742-6405-6-21) | Abstract References ORCID License | 178.53 | 60 |
| 11 | Women and HIV in Sub-Saharan Africa (10.1186/1742-6405-10-30) | Abstract ORCID License | 177.55 | 232 |
| 12 | Effect of smoking on lung function, respiratory symptoms and… (10.1186/1742-6405-7-6) | Abstract References ORCID License | 177.09 | 58 |
| 13 | Adherence to anti-retroviral therapy among HIV patients in B… (10.1186/1742-6405-6-7) | Abstract References ORCID License | 172.43 | 52 |
| 14 | Morning free and total testosterone in HIV-infected men: imp… (10.1186/1742-6405-11-6) | Abstract References ORCID License | 171.60 | 51 |
| 15 | Mobile learning for HIV/AIDS healthcare worker training in r… (10.1186/1742-6405-7-35) | Abstract References ORCID License | 169.90 | 49 |
| 16 | Bacterial vaginosis and human immunodeficiency virus infecti… (10.1186/1742-6405-4-25) | Abstract References ORCID License | 169.02 | 48 |
| 17 | Decrease of vitamin D concentration in patients with HIV inf… (10.1186/1742-6405-7-40) | Abstract References ORCID License | 169.02 | 48 |
| 18 | NGX-4010, a capsaicin 8% patch, for the treatment of painful… (10.1186/1742-6405-10-5) | Abstract References ORCID License | 168.12 | 47 |
| 19 | Trends and determinants of Comprehensive HIV and AIDS knowle… (10.1186/1742-6405-8-11) | Abstract References ORCID License | 168.12 | 47 |
| 20 | — (10.1186/1742-6405-3-10) | Abstract References ORCID License | 164.35 | 43 |
| 21 | Fat distribution and longitudinal anthropometric changes in… (10.1186/1742-6405-6-8) | Abstract References ORCID License | 163.35 | 42 |
| 22 | Sub-optimal CD4 reconstitution despite viral suppression in… (10.1186/1742-6405-5-23) | Abstract References ORCID License | 162.32 | 41 |
| 23 | Effect of HIV-1-related protein expression on cardiac and sk… (10.1186/1742-6405-5-8) | Abstract References ORCID License | 162.32 | 41 |
| 24 | Viral and cellular factors underlying neuropathogenesis in H… (10.1186/1742-6405-11-13) | Abstract ORCID License | 161.88 | 143 |
| 25 | Barriers to access prevention of mother-to-child transmissio… (10.1186/1742-6405-5-7) | Abstract References ORCID License | 159.11 | 38 |
| 26 | Gut barrier structure, mucosal immunity and intestinal micro… (10.1186/s12981-016-0103-1) | Abstract ORCID License | 159.04 | 131 |
| 27 | — (10.1186/1742-6405-3-27) | Abstract References ORCID License | 156.82 | 36 |
| 28 | Acceptability of Carraguard, a candidate microbicide and met… (10.1186/1742-6405-4-20) | Abstract References ORCID License | 156.82 | 36 |
| 29 | Further benefits by early start of HIV treatment in low inco… (10.1186/1742-6405-7-3) | Abstract References ORCID License | 156.82 | 36 |
| 30 | Multi-analyte profiling of ten cytokines in South African HI… (10.1186/1742-6405-7-36) | Abstract References ORCID License | 156.82 | 36 |
| 31 | Differential glycosylation of envelope gp120 is associated w… (10.1186/1742-6405-11-23) | Abstract References ORCID License | 155.63 | 35 |
| 32 | Markers of inflammation and coagulation indicate a prothromb… (10.1186/1742-6405-7-9) | Abstract References ORCID License | 155.63 | 35 |
| 33 | Missed opportunities for participation in prevention of moth… (10.1186/1742-6405-4-27) | Abstract References ORCID License | 153.15 | 33 |
| 34 | The feasibility of preventing mother-to-child transmission o… (10.1186/1742-6405-5-17) | Abstract References ORCID License | 153.15 | 33 |
| 35 | Long-term CD4+ lymphocyte response following HAART initiatio… (10.1186/1742-6405-8-2) | Abstract References ORCID License | 151.85 | 32 |
| 36 | Metabolic syndrome in HIV-infected individuals: underlying m… (10.1186/1742-6405-10-32) | Abstract ORCID License | 150.65 | 101 |
| 37 | — (10.1186/1742-6405-3-11) | Abstract References ORCID License | 150.51 | 31 |
| 38 | — (10.1186/1742-6405-3-28) | Abstract References ORCID License | 150.51 | 31 |
| 39 | — (10.1186/1742-6405-3-8) | Abstract References ORCID License | 150.51 | 31 |
| 40 | Chronic alcohol ingestion exacerbates skeletal muscle myopat… (10.1186/1742-6405-8-30) | Abstract References ORCID License | 150.51 | 31 |
| 41 | Experiences in conducting multiple community-based HIV preve… (10.1186/1742-6405-7-10) | Abstract References ORCID License | 147.71 | 29 |
| 42 | The impact of Highly Active Antiretroviral Therapy (HAART) o… (10.1186/1742-6405-7-19) | Abstract References ORCID License | 147.71 | 29 |
| 43 | — (10.1186/1742-6405-3-17) | Abstract References ORCID License | 143.14 | 26 |
| 44 | — (10.1186/1742-6405-3-30) | Abstract References ORCID License | 143.14 | 26 |
| 45 | Relationship between Total Lymphocyte count (TLC) and CD4 co… (10.1186/1742-6405-5-26) | Abstract References ORCID License | 143.14 | 26 |
| 46 | Health system weaknesses constrain access to PMTCT and mater… (10.1186/1742-6405-8-10) | Abstract ORCID License | 143.14 | 80 |
| 47 | Sexually transmitted infections and pre-exposure prophylaxis… (10.1186/s12981-016-0089-8) | Abstract ORCID License | 142.32 | 78 |
| 48 | Assessment of quality of life in HAART-treated HIV-positive… (10.1186/1742-6405-4-19) | Abstract References ORCID License | 139.79 | 24 |
| 49 | Community-based ART distribution system can effectively faci… (10.1186/s12981-015-0077-4) | Abstract ORCID License | 138.38 | 69 |
| 50 | — (10.1186/1742-6405-3-18) | Abstract References ORCID License | 138.02 | 23 |